Last reviewed · How we verify
NCT07173621
Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach
NA trial testing Amnioeffect in Thyroid; Wound in 334 participants. Enrolling by invitation.
1 October 2025
Quick facts
| Lead sponsor | Sarasota Memorial Health Care System |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 334 |
| Start date | 1 October 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 October 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Amnioeffect
Conditions studied
- Thyroid; Wound — all drugs for Thyroid; Wound →
- Parathyroid Diseases — all drugs for Parathyroid Diseases →
- Surgical Incision — all drugs for Surgical Incision →
- Incision — all drugs for Incision →
Sponsor
Sarasota Memorial Health Care System
Who can join
18 and older, any sex, with Thyroid; Wound or Parathyroid Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to understand how placing Amnioeffect on patients having transcutaneous thyroid or parathyroid surgery affects surgery scar appearance, pain, and the ability to swallow and compare it to patients who do not have anything placed during surgery. The Food and Drug Administration regulates the use of Amnioeffect for homologous use. Both Amnioeffect application and no Amnioeffect application are considered standard of care; however, for the purpose of this study, the use of Amnioeffect during surgery will be considered the intervention, and no Amnioeffect application will be the standard of care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07173621
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Sarasota Memorial Health Care System trials
Trials by the same sponsor.
- NCT07268547 — Wrist Reduction Intervention: Supracondylar Technique for Radial Nerve Block vs. Hematoma Block (WRIST Block Study) · Phase 4 · enrolling by invitation
- NCT07178080 — Comparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard Ultrasound · NA · enrolling by invitation
- NCT06868459 — Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Mul · enrolling by invitation
- NCT06630507 — Measuring Change in Overcoming Implicit Biases in Behavior by Emergency Care Center Providers · not yet recruiting
- NCT06683443 — Assessing the Effects of Robotic Pets on Patients With Dementia in the Acute Care Hospital Setting · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07173621 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sarasota Memorial Health Care System
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07173621.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing